• Like
  • Comment
  • Favorite

RFK Jr.'s Nomination to Head Health Department Will Shake Up Vaccine Landscape -- Market Talk

Dow Jones11-15

1122 GMT - Robert F. Kennedy Jr.'s nomination as Health and Human Services secretary will likely impact vaccine makers and the Food and Drug Administration, Jefferies analysts write. Kennedy has publicly criticized childhood and mRNA-based vaccines, the analysts say. Vaccine perception in the U.S. could suffer, leading to lower demand and sales and potentially cause outbreaks if vaccinations are not consistent over the next four years, Jefferies says. Kennedy has also been vocal on overhauling the FDA, which could alter the regulatory path, resources for biotech and drug review positions as well as impacting key FDA leadership. Bavarian Nordic shares are down 16%, with Valneva down 6%. (dominic.chopping@wsj.com)

 

(END) Dow Jones Newswires

November 15, 2024 06:22 ET (11:22 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

empty
No comments yet
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial